By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) — Accelrys today reported a 4 percent increase in revenues for its fourth fiscal quarter and a 2 percent increase for its full fiscal year.

The company said that its planned merger with scientific software firm Symyx, announced last month, has cleared the waiting period under Hart-Scott-Rodino antitrust regulations and is on track to close in early July.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers suggest that genetic variations could influence the side effects people experience when using synthetic cannabinoids, the International Business Times reports.

An analysis has examined the makeup of researchers on Twitter and what they share, Nature News reports.

At Stat News, Jim Kozubek argues that the Broad Institute is pushing the boundary of what a nonprofit is.

In PNAS this week: gut microbes may affect honeybee weight, phenotype and gene expression changes in DiGeorge syndrome, and more.